Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.285
-0.022 (-7.17%)
At close: Mar 6, 2026, 4:00 PM EST
0.285
+0.000 (0.07%)
After-hours: Mar 6, 2026, 7:47 PM EST
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $7.72 million as of March 6, 2026. Its market cap has decreased by -55.66% in one year.
Market Cap
7.72M
Enterprise Value
5.22M
1-Year Change
-55.66%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $7.72M, a decrease of -96.09%. That is a compound annual growth rate of -48.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.72M | -18.04% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiomX | 9.16M |
| CollPlant Biotechnologies | 9.14M |
| Iterum Therapeutics | 8.84M |
| Lunai Bioworks | 8.74M |
| TransCode Therapeutics | 8.56M |
| Bolt Biotherapeutics | 8.55M |
| NuCana | 8.16M |
| Pulmatrix | 7.93M |